WH Menopause/middle aged women's questions and
answers Newest RATED A+ 2025/2026 UPDATED NEW!!
2025/2026
The North American Menopause Society (NAMS) current position on the use of HT in
menopausal women include:
a. HT is indicated for the sole purpose of preventing cardiovascular disease.
b. ET for less than 5 years has significant effect on the risk for breast cancer.
c. HT is recommended for prevention of cognitive aging or dementia.
d. EPT is recommended to decrease risk of endometrial carcinoma.
Ch 12
b
Use of vaginal estrogen for treatment of VVA in a woman w/an intact uterus requires co-
administration use of progesterone.
T/F
F
For the woman who has never experienced orgasm, the clinician should
a. explain that most women achieve orgasm only through penetration if the vagina
b. suggest psychotherapy before suggesting any self help measurea
c. rec'd Kegel exercises to help inhibit orgasm response
d. diagram and describe female genital anatomy to her
Ch 16
d
There is insufficient data to support the method for discontinuing hormone therapy. Recurrence
is similar whether tapered or if cessation is abrupt
T/F
Ch 12
, T
Modifiable risk factors for osteoporosis include all but the following
a. low estrogen level
b. lifestyle factors including smoking and excessive ETOH
c. advanced age
d. lack of wt bearing exercises
Ch 12
c
What type(s) of estrogen are usually present in a woman's body in the postmenopausal years?
a. Estrone (E1) and estradiol (E2)
b. Estrone (E1) and estriol (E3)
c. Estradiol (E2) only
d. None; women do not produce estrogen after menopause.
Ch 12
a
1st line treatment to manage vaginal dryness and dyspareunia symptoms in menopause
include:
a. Clobetasol propionate 0.05% ointment BID
b. Non-hormonal water based vaginal lubricants and moisturizers
c. douching with low pH based products
d. oil based vaginal lube and moisturizers
Ch 12
b
Management of sexual arousal disorders in women may include any one of the
following except:
a. treatments that decrease blood flow to the genital tissues.
b. the use of vaginal lubricants to increase stimulation.
c. use of the Eros-CTD, a clitoral therapy device.
answers Newest RATED A+ 2025/2026 UPDATED NEW!!
2025/2026
The North American Menopause Society (NAMS) current position on the use of HT in
menopausal women include:
a. HT is indicated for the sole purpose of preventing cardiovascular disease.
b. ET for less than 5 years has significant effect on the risk for breast cancer.
c. HT is recommended for prevention of cognitive aging or dementia.
d. EPT is recommended to decrease risk of endometrial carcinoma.
Ch 12
b
Use of vaginal estrogen for treatment of VVA in a woman w/an intact uterus requires co-
administration use of progesterone.
T/F
F
For the woman who has never experienced orgasm, the clinician should
a. explain that most women achieve orgasm only through penetration if the vagina
b. suggest psychotherapy before suggesting any self help measurea
c. rec'd Kegel exercises to help inhibit orgasm response
d. diagram and describe female genital anatomy to her
Ch 16
d
There is insufficient data to support the method for discontinuing hormone therapy. Recurrence
is similar whether tapered or if cessation is abrupt
T/F
Ch 12
, T
Modifiable risk factors for osteoporosis include all but the following
a. low estrogen level
b. lifestyle factors including smoking and excessive ETOH
c. advanced age
d. lack of wt bearing exercises
Ch 12
c
What type(s) of estrogen are usually present in a woman's body in the postmenopausal years?
a. Estrone (E1) and estradiol (E2)
b. Estrone (E1) and estriol (E3)
c. Estradiol (E2) only
d. None; women do not produce estrogen after menopause.
Ch 12
a
1st line treatment to manage vaginal dryness and dyspareunia symptoms in menopause
include:
a. Clobetasol propionate 0.05% ointment BID
b. Non-hormonal water based vaginal lubricants and moisturizers
c. douching with low pH based products
d. oil based vaginal lube and moisturizers
Ch 12
b
Management of sexual arousal disorders in women may include any one of the
following except:
a. treatments that decrease blood flow to the genital tissues.
b. the use of vaginal lubricants to increase stimulation.
c. use of the Eros-CTD, a clitoral therapy device.
